Investigational Oral Carbapenem Antibiotic Gets Fast-Tracked for cUTI, Acute Pyelonephritis
Spero Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation for SPR994 (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)